Cardiotoxicity of Oncologic Treatments
eBook - PDF

Cardiotoxicity of Oncologic Treatments

  1. 196 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Cardiotoxicity of Oncologic Treatments

About this book

The possibility of getting a cardiovascular disease or cancer increases with advancing age. At the same time, relevant improvements in cancer therapy have resulted in the improvement of quality of life and the increasement of the survival rate of such patients. As a result we have larger number of patients that experience the cardiac side effects of chemotherapy. The extent of cardiotoxicity is variable, depending on the type of drug used, combination with other drugs, prior mediastinal radiotherapy and the presence of cardiovascular risk factors or history of heart disease. Early detection of the patients proneness for developing cardiotoxicity is the key issue to decrease morbidity and mortality. It also facilitates more tailored therapeutic interventions. Therefore, the collaboration and interaction of cardiology and oncology may contribute to reducing the cardiovascular adverse effects and improving the results in the treatment of patients with cancer.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Cardiotoxicity of Oncologic Treatments by Manuela Fiuza in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
IntechOpen
Year
2012
Print ISBN
9789535102731
eBook ISBN
9789535168935
Topic
Medicine
Subtopic
Cardiology

Table of contents

  1. Cardiotoxicity of Oncologic Treatments
  2. Contents
  3. Preface
  4. Chapter 1 Cardiovascular Pathophysiology Produced by Natural Toxins and Their Possible Therapeutic Implications
  5. Chapter 2 Role of Nitric Oxide in Isoproterenol-Induced Myocardial Infarction
  6. Chapter 3 Cardiac Complications of Cancer Treatment
  7. Chapter 4 Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity
  8. Chapter 5 Doxorubicin-Induced Oxidative Injury of Cardiomyocytes – Do We Have Right Strategies for Prevention?
  9. Chapter 6 Trastuzumab and Cardiotoxicity
  10. Chapter 7 Early Detection and Prediction of Cardiotoxicity – Biomarker and Echocardiographic Evaluation